Nutrition news

Reckitt weighs selling off-the-shelf infant nutrition units – Bloomberg News

Mead Johnson’s Enfamil baby formula is displayed on a store shelf in New York, U.S., February 10, 2017. REUTERS/Brendan McDermid

Join now for FREE unlimited access to Reuters.com

Register

June 28 (Reuters) – Britain’s Reckitt Benckiser Group (RKT.L) is considering halting the sale of its infant nutrition unit as high-profile deals fall victim to a deteriorating funding market, Bloomberg News reported on Tuesday. .

Talks between infant formula maker Enfamil and potential buyers have stalled in recent weeks, the report said, citing people familiar with the matter.

Reckitt declined to comment on the report.

Join now for FREE unlimited access to Reuters.com

Register

Bloomberg News reported that disagreements over valuation, a lack of available funding and an ongoing infant formula crisis in the United States have complicated the company’s sales efforts.

The infant formula crisis in the United States had boosted Reckitt’s profits and helped it capture the top spot in a $5.8 billion-a-year market. Read more

Reckitt has not made a final decision on whether to officially withdraw the sale, according to the report.

Shares of the consumer goods company were trading up 0.1% at 1419 GMT.

Join now for FREE unlimited access to Reuters.com

Register

Reporting by Radhika Anilkumar in Bengaluru; Editing by Krishna Chandra Eluri

Our standards: The Thomson Reuters Trust Principles.